These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11802579)

  • 1. Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics.
    Platt R; Davis R; Finkelstein J; Go AS; Gurwitz JH; Roblin D; Soumerai S; Ross-Degnan D; Andrade S; Goodman MJ; Martinson B; Raebel MA; Smith D; Ulcickas-Yood M; Chan KA
    Pharmacoepidemiol Drug Saf; 2001; 10(5):373-7. PubMed ID: 11802579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organizational context and taxonomy of health care databases.
    Shatin D
    Pharmacoepidemiol Drug Saf; 2001; 10(5):367-71. PubMed ID: 11802578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of research in integrated healthcare systems: the HMO Research Network.
    Vogt TM; Elston-Lafata J; Tolsma D; Greene SM
    Am J Manag Care; 2004 Sep; 10(9):643-8. PubMed ID: 15515997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues in pooling administrative data for economic evaluation.
    Meenan RT; Goodman MJ; Fishman PA; Hornbrook MC; O'Keeffe-Rosetti MC; Bachman DJ
    Am J Manag Care; 2002 Jan; 8(1):45-53. PubMed ID: 11814172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Databases for outcomes research: what has 10 years of experience taught us?
    Bosco L
    Pharmacoepidemiol Drug Saf; 2001; 10(5):445-55. PubMed ID: 11802591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How effectively do managed care organizations influence prescribing and dispensing decisions?
    Carroll NV
    Am J Manag Care; 2002 Dec; 8(12):1041-54. PubMed ID: 12500881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Struggling to invent high-reliability organizations in health care settings: Insights from the field.
    Dixon NM; Shofer M
    Health Serv Res; 2006 Aug; 41(4 Pt 2):1618-32. PubMed ID: 16898982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a group outpatient visit model for chronically ill older health maintenance organization members: a 2-year randomized trial of the cooperative health care clinic.
    Scott JC; Conner DA; Venohr I; Gade G; McKenzie M; Kramer AM; Bryant L; Beck A
    J Am Geriatr Soc; 2004 Sep; 52(9):1463-70. PubMed ID: 15341547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Have HMOs broadened their hospital networks?: Changes in HMO hospital networks in California, 1999-2003.
    Melnick GA; Ketcham JD
    Med Care; 2008 Mar; 46(3):339-42. PubMed ID: 18388850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations.
    Brown JS; Kulldorff M; Petronis KR; Reynolds R; Chan KA; Davis RL; Graham D; Andrade SE; Raebel MA; Herrinton L; Roblin D; Boudreau D; Smith D; Gurwitz JH; Gunter MJ; Platt R
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):226-34. PubMed ID: 19148879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accessing third-party data for research: trust me? Trust me not?
    Dreyer NA
    Pharmacoepidemiol Drug Saf; 2001; 10(5):385-8. PubMed ID: 11802581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of HMO mergers and acquisitions on financial performance.
    Weech-Maldonado R
    J Health Care Finance; 2002; 29(2):64-77. PubMed ID: 12462660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ryan White CARE Act Title IV programs: a preliminary characterization of benefits and costs.
    Abramowitz S; Greene D
    AIDS Public Policy J; 2005; 20(3-4):108-25. PubMed ID: 17624034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMO databases: fertile ground for epidemiological research.
    Lapham SC; Montgomery KA; Hoy WE
    Comput Healthc; 1990 Sep; 11(9):18-20, 22, 24. PubMed ID: 10107928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Categorizing race and ethnicity in the HMO Cancer Research Network.
    Ford ME; Hill DD; Nerenz D; Hornbrook M; Zapka J; Meenan R; Greene S; Johnson CC
    Ethn Dis; 2002; 12(1):135-40. PubMed ID: 11913601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the emergency medicine services for children research agenda: priorities for multicenter research in pediatric emergency care.
    Miller SZ; Rincón H; Kuppermann N;
    Acad Emerg Med; 2008 Apr; 15(4):377-83. PubMed ID: 18370994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of generic-only drug coverage in a Medicare HMO.
    Christian-Herman J; Emons M; George D
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-455-68. PubMed ID: 15471765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USAID steps up anti-AIDS program.
    USAID Highlights; 1991; 8(3):1-4. PubMed ID: 12284337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMO provider networks in Medicare+Choice: comparing Medicare and commercial lines of business.
    Lake T; Gold M; Hurley R
    Manag Care Q; 2001; 9(4):16-22. PubMed ID: 11813453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.